Frontlight ResearchEarly access
Trial site
Specjalistyczne Gabinety Lekarskie Landa
- 3running trials
- 5closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease5 trials
- Ulcerative colitis3 trials
- Migraine1 trial
- Psoriasis1 trial
- Phase
- Phase 26 trials
- Phase 2/31 trial
- Phase 31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Lead sponsor
- Arena Pharmaceuticals Inc.1 trial
- Celgene International II S.a.r.l.1 trial
- H. Lundbeck A/S1 trial
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
- Sanofi1 trial
- and 3 more
Running trials
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Closed trials
Completed
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026